Login
$BMRN
$57.99 +$0.76 (1.33%) Live

Company Executives

Officer Age Joined 2025 pay Source
Alexander Hardy Also a director
President and Chief Executive Officer
57 Not stated $21,927,563
Brian R. Mueller
Executive Vice President and Chief Financial Officer
52 2002 $6,831,812
G. Eric Davis
Executive Vice President, Chief Legal Officer and Secretary
55 2004 Not reported
Gregory R. Friberg
EVP, Chief R&D Officer
Title from the Form 4 dated Sep 30, 2026
52 Not stated $7,174,583
C. Greg Guyer
Executive Vice President and Chief Technical Officer
64 Not stated $5,691,680
Cristin Hubbard
Executive Vice President and Chief Commercial Officer
50 Not stated $5,713,695
Rashmi Ramchandani
Vice President and Chief Accounting Officer
47 Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 21, 2026 · updated by the 8-K of Sep 14, 2026

Directors
12
serving now
Independent
11 of 12
stated in the proxy
Average tenure
4.5 years
from year joined
CEO also chairs the board
No
Ian T. Clark
Director Age On board Independent Committees Other public boards 2025 pay Source
Ian T. Clark
65 2025
1 year
Independent None stated None stated $451,230
Alexander Hardy
57 2023
3 years
Not independent None stated None stated Paid as CEO
Elizabeth McKee Anderson
68 2019
7 years
Independent
Compensation Committee · Chair
GSK plc, Insmed, Inc., Revolution Medicines, Inc. $505,035
Barbara W. Bodem
58 2023
3 years
Independent None stated Enovis Corp., Option Care Health, Inc. $487,035
Athena Countouriotis
54 2023
3 years
Independent None stated Iovance Biotherapeutics, Inc. $493,660
Willard Dere
72 2016
10 years
Independent
Science and Technology Committee · Chair
Seres Therapeutics, Inc., Metagenomi, Inc. $509,035
Mark J. Enyedy
62 2023
3 years
Independent
CGN Committee · Chair
Charles River Laboratories International, Inc. $501,285
Maykin Ho
73 2021
5 years
Independent None stated Agios Pharmaceuticals Inc., Kyntra Bio, Inc., Neumora Therapeutics, Inc. Not stated
Robert J. Hombach
60 2017
9 years
Independent
Audit Committee · Chair
Embecta Corporation $509,535
Timothy P. Walbert
59 2025
1 year
Independent None stated Mirum Pharmaceuticals, Inc., Century Therapeutics, Inc., Sagimet Biosciences Inc. $492,785
Robert Plenge Joined Sep 10, 2026
- - Independent
Science and Technology Committee
- -
Meier Leaving at the meeting
Not stated Not stated Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 21, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support